Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy
Minggang Zhang(Memorial Sloan Kettering Cancer Center), Morgan Huse(Memorial Sloan Kettering Cancer Center), Margaret Hannum(Memorial Sloan Kettering Cancer Center), Zeguo Zhao(Memorial Sloan Kettering Cancer Center), Venkatraman Seshan(Memorial Sloan Kettering Cancer Center), Andrea Schietinger(Memorial Sloan Kettering Cancer Center), Michel Sadelain(Columbia University Irving Medical Center), Andrew Scott(Memorial Sloan Kettering Cancer Center), Yuri Pritykin(Princeton University), Timothy A. Chan(Cleveland Clinic), Viraj R. Sanghvi(Memorial Sloan Kettering Cancer Center), Hans‐Guido Wendel(Memorial Sloan Kettering Cancer Center), Fengshen Kuo(Memorial Sloan Kettering Cancer Center)
Cited by 13
Related Papers
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
|Annals of Oncology|2018|2.9k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
The Conformational Plasticity of Protein Kinases
|Cell|2002|1.8k
Gene therapy comes of age
|Science|2018|1.4k